Table 2.
Changes in circulating DPP-4/sCD26 concentrations and metabolic parameters
| Baseline | After 2 weeks | P value | |
|---|---|---|---|
| AST (IU/L) | 32.3 ± 23.1 | 30.4 ± 18.9 | 0.48 |
| ALT (IU/L) | 43.1 ± 38.9 | 39.9 ± 30.9 | 0.47 |
| γ-GTP (IU/L) | 59.6 ± 66.9 | 47.9 ± 51.7 | 0.004 |
| LDL-C (mg/dl) | 118.0 ± 31.9 | 104.2 ± 28.8 | 0.00008 |
| HDL-C (mg/dl) | 41.3 ± 9.3 | 39.0 ± 8.1 | 0.004 |
| TG (mg/dl) | 159.2 ± 86.1 | 133.8 ± 60.5 | 0.02 |
| MDA-LDL (U/L) | 136.2 ± 49.7 | 115.2 ± 35.6 | 0.00003 |
| RLP-C (mg/dl) | 7.4 ± 5.8 | 5.4 ± 3.4 | 0.02 |
| DHLA (μg/ml) | 38.4 ± 16.5 | 30.1 ± 8.4 | 0.0002 |
| AA (μg/ml) | 207.3 ± 58.9 | 192.7 ± 45.2 | 0.003 |
| EPA (μg/ml) | 60.2 ± 35.6 | 57.2 ± 27.0 | 0.36 |
| DHA (μg/ml) | 139.8 ± 50.9 | 137.3 ± 43.7 | 0.54 |
| EPA/AA | 0.30 ± 0.20 | 0.31 ± 0.16 | 0.80 |
| hsCRP (mg/dl) | 0.25 ± 0.34 | 0.22 ± 0.36 | 0.90 |
| DPP-4/sCD26 (ng/ml) | 1002.6 ± 393.9 | 892.0 ± 399.4 | 0.003 |
MDA-LDL, malondialdehyde-modified LDL; RLP-C, remnant like particls cholesterol; DHLA, dihomo γ-linolenic acid; AA, arachidonic acid; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid